Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions, enabling the formation of carbon-carbon bonds in pharmaceutical synthesis. Its boronate ester group facilitates coupling with aryl halides under palladium catalysis, making it valuable in the development of complex organic molecules, particularly in drug discovery and the production of bioactive compounds. The sulfonamide group enhances solubility and can participate in hydrogen bonding, which is beneficial in medicinal chemistry for improving target binding and pharmacokinetic properties.